These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 17024283)

  • 1. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
    Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell recognition of MHC class I. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells.
    Kurago ZB; Smith KD; Lutz CT
    J Immunol; 1995 Mar; 154(6):2631-41. PubMed ID: 7876538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.
    Poenaru S; Lamas JR; Folkers G; López de Castro JA; Seebach D; Rognan D
    J Med Chem; 1999 Jul; 42(13):2318-31. PubMed ID: 10395472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.
    Burrows JM; Wynn KK; Tynan FE; Archbold J; Miles JJ; Bell MJ; Brennan RM; Walker S; McCluskey J; Rossjohn J; Khanna R; Burrows SR
    Eur J Immunol; 2007 Apr; 37(4):946-53. PubMed ID: 17357107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended repertoire of permissible peptide ligands for HLA-B*2702.
    Raghavan M; Lebrón JA; Johnson JL; Bjorkman PJ
    Protein Sci; 1996 Oct; 5(10):2080-8. PubMed ID: 8897608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
    Villadangos JA; Galocha B; López de Castro JA
    J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
    van der Burg SH; Visseren MJ; Brandt RM; Kast WM; Melief CJ
    J Immunol; 1996 May; 156(9):3308-14. PubMed ID: 8617954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.
    Bell MJ; Burrows JM; Brennan R; Miles JJ; Tellam J; McCluskey J; Rossjohn J; Khanna R; Burrows SR
    Mol Immunol; 2009 May; 46(8-9):1911-7. PubMed ID: 19157553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of peptide binding to the murine MHC class I H-2Kk molecule. Sequencing of the bound peptides and direct binding of synthetic peptides to isolated class I molecules.
    Brown EL; Wooters JL; Ferenz CR; O'Brien CM; Hewick RM; Herrmann SH
    J Immunol; 1994 Oct; 153(7):3079-92. PubMed ID: 7522249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide selection by MHC class I molecules.
    Schumacher TN; De Bruijn ML; Vernie LN; Kast WM; Melief CJ; Neefjes JJ; Ploegh HL
    Nature; 1991 Apr; 350(6320):703-6. PubMed ID: 1708852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
    Weichold FF; Mueller S; Kortsik C; Hitzler WE; Wulf MJ; Hone DM; Sadoff JC; Maeurer MJ
    Genes Immun; 2007 Jun; 8(4):334-43. PubMed ID: 17429413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
    Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
    Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
    Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
    Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
    Wu S; Gorski J; Eckels DD; Newton-Nash DK
    J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.